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Zika virus infections have been known in Africa and Asia 
since the 1940s, but the virus’s 
geographic range has expanded 
dramatically since 2007. Between 
January 1, 2007, and March 1, 
2016, local transmission was re-
ported in an additional 52 coun-
tries and territories, mainly in the 
Americas and the western Pacific, 
but also in Africa and southeast 
Asia. Zika virus infections ac-
quired by travelers visiting those 
countries have been discovered at 
sites worldwide. Aedes aegypti mos-
quitoes are the principal vectors, 
though other mosquito species 
may contribute to transmission. 
The virus was found to be neuro-
tropic in animals in experiments 
conducted in the 1950s, and re-
cent experiments have shown how 
it can cause neural-cell death. A 
rise in the incidence of Guillain–
Barré syndrome, an immune-
mediated flaccid paralysis often 
triggered by infection, was first 
reported in 2013 during a Zika 
outbreak in French Polynesia. An 
increase in the incidence of mi-
crocephaly, a clinical sign that 
can be caused by underdevelop-
ment of the fetal brain, was first 
reported in northeastern Brazil 
in 2015, after Zika virus transmis-
sion had been confirmed there. 
These reports of excess cases of 
Guillain–Barré syndrome and mi-
crocephaly led the World Health 
Organization (WHO) to declare a 
Public Health Emergency of Inter-
national Concern on February 1, 
2016, and to recommend acceler-
ated research into possible causal 
links between Zika virus and 
neurologic disorders.1
As researchers investigate 
whether and by what mecha-
nisms Zika virus infections could 
affect the nervous system, there 
is a key question for public 
health: How can currently avail-
able evidence about causality 
guide the choice and implemen-
tation of interventions? For this 
purpose, the WHO is developing 
a framework for the systematic 
appraisal of evidence about these 
causal relationships. How does 
the available evidence inform 
current WHO recommendations, 
and what are the priorities for re-
search going forward?
Besides advancing scientific 
understanding, the main practi-
cal purpose of investigating cau-
sality is to evaluate, as accurately 
as possible, what reduction in 
the incidence of illness (here, 
especially neurologic disorders) 
can be expected from reducing 
human exposure to the putative 
cause (Zika virus infection). The 
conceptual framework is based 
on factors first proposed by Brad-
ford Hill and commonly used 
to assess causality: temporality 
(cause precedes effect), biologic 
plausibility of causal mechanisms, 
consistency (same association 
found in different studies and 
populations), strength of associa-
tion (as measured by risk ratio, 
rate ratio, or odds ratio in cohort 
or case–control studies), exclu-
sion of alternative explanations, 
dose–response relationship, ces-
sation (removing the supposed 
cause reverses the effect), and 
analogy to cause-and-effect rela-
tionships in other diseases.2 Tem-
porality is the single necessary 
condition; none of the factors on 
its own is sufficient.
Causal relationships cannot be 
proven with absolute certainty in 
epidemiologic studies, but these 
factors help analysts judge the 
existence and strength of possible 
causal links. Their assessment 
should be complemented by con-
trolled experiments, the most 
robust approach to drawing in-
ferences about cause and effect.
A systematic strategy for 
identifying relevant evidence will 
enable a transparent and replica-
ble approach that can be updat-
ed to capture new information. 
Study methods can be assessed 
for risks of selection and mea-
surement bias, confounding, and 
the effect of chance. To illustrate 
the approach, we conducted a 
search of PubMed and selected 
journal and public health web-
sites for information posted 
through March 4, 2016. The ta-
ble and the Supplementary Ap-
pendix (available with the full 
text of this article at NEJM.org) 
provide a preliminary summary 
of population- and individual-
level studies on possible associa-
tions between Zika virus infection 
and Guillain–Barré syndrome or 
microcephaly.
We found three published re-
ports on Guillain–Barré syn-
drome studied at the population 
level. During the 2013–2014 out-
break in French Polynesia, the 
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rise and fall of Zika virus infec-
tions was followed by a similar 
rise and fall in the incidence of 
Guillain–Barré syndrome, with a 
delay of about 3 weeks.3 In the 
Americas, Guillain–Barré syn-
drome in the presence of Zika 
virus has now been reported to 
the WHO from Brazil, Colombia, 
El Salvador, Martinique, Panama, 
Puerto Rico, Suriname, and Vene-
zuela, but we found no reports 
from these countries linking the 
syndrome with trends in Zika vi-
rus infections.
One study of microcephaly 
showed a higher-than-expected 
incidence in the state of Paraíba, 
Brazil, during the period when 
Zika transmission began, but data 
on the timing of Zika infections 
were not available (see table). In 
the state of Bahia, Brazil, an out-
break of cases of acute rash, sus-
pected to be Zika virus disease, 
was followed by an increase in 
cases of microcephaly. Additional 
surveillance data describing the 
temporal relationship between 
Zika infections and neurologic 
disorders are likely to be pub-
lished soon. Some recent epide-
miologic observations invite fur-
ther investigation: microcephaly 
has been reported in association 
with Zika infection in Brazil, but 
not yet in neighboring countries, 
perhaps because it is still too 
soon after the introduction of 
the virus. An outbreak of Zika vi-
rus infection in Cape Verde dur-
ing 2015–2016 involving thou-
sands of cases and possibly 
caused by an African strain of 
the virus has not been linked to 
any neurologic disorders.4
At the level of individual pa-
tients, we found 3 studies on 
Guillain–Barré syndrome and 14 
on microcephaly. The only pub-
lished case–control study showed, 
among other results, that 41 of 
42 patients with Guillain–Barré 
syndrome diagnosed during the 
2013–2014 outbreak in French 
Polynesia (98%) were carrying 
Zika virus antibodies, as com-
pared with 35 of 98 hospitalized 
controls (odds ratio, 59.7; 95% 
confidence interval, 10.4 to ∞).3 
Serologic tests excluded some 
other infectious triggers for 
Guillain–Barré syndrome, and 
there was no association between 
the syndrome and exposure to 
dengue, which has the same mos-
quito vector and was circulating at 
the same time as the Zika virus 
outbreak.
One prospective study has 
compared ultrasound findings in 
pregnant women with confirmed 
Zika virus disease and in women 
with rash apparently from other 
causes (see table). Ultrasound 
findings were abnormal, includ-
ing indications of microcephaly, 
in 12 of 42 women with Zika vi-
rus disease and were normal in 
all 16 women with no Zika virus 
disease. Eleven other reports, pub-
lished between November 2015 
and February 2016, involved a to-
tal of 93 neonates or fetuses with 
microcephaly, all in, or linked to, 
Brazil. In 9 of the 93 cases, Zika 
infection was detected in fetal or 
neonatal brain tissue or in amni-
otic fluid. In 4 cases, Zika virus 
was found in the brain but not in 
other organs on postmortem ex-
amination. In most case reports 
or case series, other infections 
and toxic exposures known to 
cause microcephaly were not com-
pletely excluded. One additional 
report compiled after the Zika vi-
rus outbreak in French Polynesia 
identified 17 cases of fetal or neo-
natal brain malformations, which 
included a number of cases of 
microcephaly.
The prevailing uncertainty 
about Zika virus infection and its 
consequences is now driving a vig-
orous program of research. One 
case–control study of Guillain–
Barré syndrome and one cohort 
study of pregnant women de-
scribed above provide evidence 
for a causal link. However, most 
of the data summarized here de-
rive from studies whose designs 
are typically classified as weak, 
and the data are not entirely con-
sistent. The available data are 
mainly observations regarding 
temporal associations between 
infection and disease from rou-
tine population surveillance and 
clinical and pathological studies 
of single cases or groups of cases. 
Such data are essential for the 
discovery of new phenomena and 
as a source of testable hypothe-
ses about cause and effect,5 but a 
more comprehensive approach to 
causality is needed. The WHO 
framework will set out research 
questions to address the various 
dimensions of causality as they 
apply to Zika virus and neuro-
logic disorders and will ensure a 
systematic review of the litera-
ture to synthesize the evidence. 
Further case–control and cohort 
studies are already under way to 
fill critical knowledge gaps.
Even with limited evidence 
linking Zika virus to neurologic 
disorders, the severe potential 
risks demand decisive, immediate 
action to protect public health. 
The WHO recommends applying 
key interventions such as inten-
sive mosquito control; personal 
protection against mosquito bites; 
provision of appropriate clinical 
care for all patients with Guil-
lain–Barré syndrome and for 
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women before, during, and after 
pregnancy; and prevention of Zika 
virus transmission through sexual 
contact or blood transfusion.4 
Most of these are not new in-
terventions, but they do need 
strengthening. Populations must 
be informed of the potential cur-
rent and future risks of neuro-
logic disorders, wherever the vi-
rus is being or could be locally 
transmitted and in other regions 
inhabited by the mosquito vec-
tors. As the putative link between 
Zika virus and neurologic disor-
ders is reinforced, refined, or 
even refuted, public health mea-
sures will be adjusted accordingly.
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are available with the full text of this article 
at NEJM.org.
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